Nachman Norwood & Parrott’s Cerence CRNC Stock Holding History

Nachman Norwood & Parrott’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32	Closed	-$2K	–	423
2020 Q3	$2K	Buy	+32	New	+$1.54K	﹤0.01%	1077

Other funds holding CRNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Nachman Norwood & Parrott's CRNC Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Cerence (CRNC) in Q4 2020, closing a stake of 32 shares — an estimated $2K sold.

Nachman Norwood & Parrott first reported a position in CRNC in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 326 funds tracked by Wall St. Rank hold CRNC as of Q4 2020.

Nachman Norwood & Parrott reported no remaining Cerence position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 32 Cerence shares in Q4 2020, an estimated $2K.
Nachman Norwood & Parrott first reported a position in Cerence in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's Cerence position peaked at $2K in Q3 2020.
326 funds tracked by Wall St. Rank held Cerence as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.